Holley

Holley Group is a prominent Chinese industrial conglomerate with a core focus on the pharmaceutical and healthcare sectors. The company is globally recognized for its pioneering role in the industrialization of Artemisinin, a breakthrough anti-malarial compound derived from traditional Chinese medicine. Through its major subsidiaries, such as KPC Pharmaceuticals and Holley Pharmaceutical, the group develops, manufactures, and distributes a wide range of products including botanical drugs, chemical pharmaceuticals, and medical devices. Holley's anti-malarial therapies, notably Duo-Cotecxin, are critical components of global health initiatives in malaria-endemic regions like Africa and Southeast Asia. In addition to infectious diseases, the company has a strong presence in cardiovascular and cerebrovascular health. Holley continues to leverage its expertise in natural product extraction and modern pharmaceutical manufacturing to expand its international footprint.